Phase I/Ii Radioimmunotherapy Trial With Y-90-Labeled Epratuzumab (Lymphocide (Tm) Anti-Cd22 Monoclonal Antibody) In Relapsed/Refractory Non-Hodgkin'S Lymphoma (Nhl).
JOURNAL OF NUCLEAR MEDICINE（2001）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要